Exhibit 107.1
Calculation of Filing Fee Tables
FORM S-8
(Form Type)
RAIN ONCOLOGY INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly
Registered Securities
| Security Type | Security Class Title (1) | Fee Calculation Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee |
| Equity | Common stock, par value $0.001 per share | Rule 457(a) (2) |
1,451,611 (4) |
$8.31 | $12,062,887.41 | $110.20 per $1,000,000 | $1,329.33 |
| Equity | Common stock, par value $0.001 per share | Rule 457(a) (3) |
362,902 (5) |
$8.31 | $3,015,715.62 | $110.20 per $1,000,000 | $332.33 |
| Total Offering Amounts | $15,078,603.03 | $1,661.66 | |||||
| Total Fee Offsets | — | ||||||
| Net Fee Due | $1,661.66 | ||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 (this “Registration Statement”) shall also cover any additional shares of common stock, par value $0.001 per share (the “Common Stock”) of Rain Oncology Inc. (the “Registrant”) that become issuable under the Rain Oncology Inc. 2021 Equity Incentive Plan (the “2021 Plan”) and the Rain Oncology Inc. 2021 Employee Stock Purchase Plan (the “ESPP”). | |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) of the Securities Act, and based on the average of the high and low sale prices of the Common Stock, as quoted on the Nasdaq Global Select Market, on May 4, 2023. | |
| (3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) of the Securities Act, and based on the average of the high and low sale prices of the Common Stock, as quoted on the Nasdaq Global Select Market, on May 4, 2023. Pursuant to the ESPP, the purchase price of a share of Common Stock is 85% of the fair market value of the Common Stock. | |
| (4) | Represents 1,451,611 additional shares of Common Stock reserved for issuance under the 2021 Plan. | |
| (5) | Represents 362,902 additional shares of Common Stock reserved for issuance under the ESPP. |